中国医学科学院医药生物技术研究所

当前位置:首页-科研动态-论文著作
A new GntR family regulator Ste1 in Streptomyces sp. 139.
来源: 时间:2014-07-08 浏览次数:3162
Appl Microbiol Biotechnol. 2013 Oct;97(19):8673-82. doi: 10.1007/s00253-013-5076-6. Epub 2013 Jul 5.
A newGntRfamilyregulatorSte1 in Streptomycessp. 139.
  • Key Laboratory of Biotechnology of Antibiotics, Ministry of Health, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
Abstract
The novel exopolysaccharide Ebosin produced by Streptomyces sp. 139 has remarkable in vivo antirheumatic arthritis activity, and its biosynthesis gene cluster (ste) consisting of 27 ORFs has been identified. The present investigation focused on the function of ste1 gene. Database searching revealed that Ste1 is homologous to the GntR family regulator originated from microbes. To confirm its function in Ebosin biosynthesis, the gene was disrupted. The mutant strain Streptomyces sp. 139 D1 was found to have a much higher Ebosin production than that of the wild-type strain, whilst the complementation strain Streptomyces sp. 139 C1 showed a decrease in the exopolysaccharide produced. Real-time qPCR analysis indicated that in the mutant strain Streptomyces sp. 139 D1, transcription levels of gene ste5, ste8, and ste17 increased significantly compared with those in the wild-type strain. The electrophoretic mobility shift assay demonstrated that Ste1 binds with higher affinity to the promoter 1 and 3 regions in the ste gene cluster. It is concluded that ste1 plays the negative regulation as a transcription repressor during Ebosin biosynthesis. Growing on minimal agar medium supplemented with glucose and R2YE agar medium, the mutant strain Streptomyces sp. 139 D1 exhibited a Bld phenotype.